CA2868614A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
AU2002332628B2
(en)
|
2001-08-23 |
2007-07-26 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US7329405B2
(en)
|
2001-08-23 |
2008-02-12 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
GB0208817D0
(en)
*
|
2002-04-17 |
2002-05-29 |
European Molecular Biology Lab Embl |
Method for producing monoclonal antibodies
|
ZA200506724B
(en)
*
|
2003-02-26 |
2007-03-28 |
Genmab As |
Human antibodies specific for interleukin 15 (IL-15)
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
US20050123542A1
(en)
*
|
2003-11-06 |
2005-06-09 |
Genmab A/S |
Methods for treating disorders involving monocytes
|
JP5553963B2
(ja)
*
|
2004-10-22 |
2014-07-23 |
アムジエン・インコーポレーテツド |
組換え抗体をリフォールディングする方法
|
CA2590778A1
(en)
*
|
2004-12-13 |
2006-06-22 |
Cytos Biotechnology Ag |
Il-15 antigen arrays and uses thereof
|
CN101500607B
(zh)
|
2005-05-16 |
2013-11-27 |
阿布维生物技术有限公司 |
TNFα抑制剂治疗腐蚀性多关节炎的用途
|
EP1909831A4
(en)
|
2005-06-14 |
2013-02-20 |
Amgen Inc |
PREPARATIONS OF SPONTANEOUS TAMPING PROTEINS
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
WO2008100805A2
(en)
|
2007-02-09 |
2008-08-21 |
Genentech, Inc. |
Anti-robo4 antibodies and uses therefor
|
EP2171451A4
(en)
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
EP2197421A1
(en)
*
|
2007-08-31 |
2010-06-23 |
Amgen, Inc |
Solid-state protein formulation
|
MX2010002683A
(es)
*
|
2007-09-14 |
2010-03-26 |
Amgen Inc |
Poblaciones de anticuerpos homogeneos.
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
EP2219602A1
(en)
|
2007-11-15 |
2010-08-25 |
Amgen, Inc |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
AR069501A1
(es)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
|
EP2098536A1
(en)
|
2008-03-05 |
2009-09-09 |
4-Antibody AG |
Isolation and identification of antigen- or ligand-specific binding proteins
|
MX2010010503A
(es)
*
|
2008-03-24 |
2010-11-09 |
Abbott Biotech Ltd |
Metodos y composiciones para tratar perdida osea.
|
CU23716A1
(es)
|
2008-09-30 |
2011-10-05 |
Ct Ingenieria Genetica Biotech |
Péptido antagonista de la actividad de la interleucina-15
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
AR077595A1
(es)
|
2009-07-27 |
2011-09-07 |
Genentech Inc |
Tratamientos de combinacion
|
US9321823B2
(en)
|
2009-09-02 |
2016-04-26 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
ES2565208T3
(es)
|
2009-12-11 |
2016-04-01 |
F. Hoffmann-La Roche Ag |
Anticuerpos anti-VEGF-C y métodos de uso de los mismos
|
CN107095846A
(zh)
|
2009-12-21 |
2017-08-29 |
霍夫曼-拉罗奇有限公司 |
抗体配制剂
|
EA032537B1
(ru)
|
2010-06-07 |
2019-06-28 |
Эмджен Инк. |
Способ работы устройства для доставки лекарственного средства
|
SI2580243T1
(sl)
|
2010-06-09 |
2020-02-28 |
Genmab A/S |
Protitelesa proti humanemu CD38
|
CN106084053B
(zh)
|
2010-06-15 |
2020-01-17 |
根马布股份公司 |
针对组织因子的人抗体药物缀合物
|
EP2625197B1
(en)
|
2010-10-05 |
2016-06-29 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
MX341790B
(es)
|
2011-03-31 |
2016-09-02 |
Amgen Inc |
Adaptador de viales y sistema.
|
JP6038884B2
(ja)
|
2011-04-20 |
2016-12-07 |
アムゲン・インコーポレーテッド |
自動式注射装置
|
CN102250243B
(zh)
*
|
2011-07-01 |
2013-08-28 |
华绍炳 |
抗白细胞介素-15抗体
|
PT2734538T
(pt)
*
|
2011-07-18 |
2018-08-02 |
Iba Gmbh |
Processo para corar, de forma reversível, uma célula-alvo
|
LT3045189T
(lt)
|
2011-10-14 |
2018-06-25 |
Amgen Inc. |
Inžektorius ir surinkimo būdas
|
EP4234694A3
(en)
|
2012-11-21 |
2023-09-06 |
Amgen Inc. |
Drug delivery device
|
ES2730011T3
(es)
*
|
2013-02-20 |
2019-11-07 |
Innate Pharma |
Un compuesto que se une específicamente a KIR3DL2 para el uso en el tratamiento de linfoma de células T periférico
|
US20140314778A1
(en)
|
2013-03-13 |
2014-10-23 |
Genentech, Inc. |
Formulations with reduced oxidation
|
MX370416B
(es)
|
2013-03-13 |
2019-12-10 |
Genentech Inc |
Formulaciones con oxidacion reducida.
|
BR112015022210A8
(pt)
|
2013-03-13 |
2018-01-23 |
Genentech Inc |
formulações de anticorpo
|
US10653779B2
(en)
|
2013-03-13 |
2020-05-19 |
Genentech, Inc. |
Formulations with reduced oxidation
|
JP6389236B2
(ja)
|
2013-03-13 |
2018-09-12 |
ジェネンテック, インコーポレイテッド |
酸化還元製剤
|
JP6768501B2
(ja)
|
2013-03-15 |
2020-10-14 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入機、および自動注入機システム
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
KR102235452B1
(ko)
|
2013-03-15 |
2021-04-02 |
제넨테크, 인크. |
항산화제를 함유하는 세포 배양 조성물 및 폴리펩티드 생산 방법
|
AU2014238267B2
(en)
|
2013-03-22 |
2019-08-15 |
Amgen Inc. |
Injector and method of assembly
|
MY175472A
(en)
|
2013-09-27 |
2020-06-29 |
Genentech Inc |
Anti-pdl1 antibody formulations
|
JP7051293B2
(ja)
|
2013-10-24 |
2022-04-11 |
アムジエン・インコーポレーテツド |
温度感知制御を伴う薬剤送達システム
|
KR102458637B1
(ko)
|
2013-10-24 |
2022-10-24 |
암겐 인코포레이티드 |
주입기 및 조립 방법
|
AU2014364606A1
(en)
|
2013-12-17 |
2016-07-07 |
Genentech, Inc. |
Combination therapy comprising OX40 binding agonists and PD-1 axis binding antagonists
|
BR112016013741A2
(pt)
|
2013-12-17 |
2017-10-03 |
Genentech Inc |
Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos
|
KR20240017102A
(ko)
|
2013-12-17 |
2024-02-06 |
제넨테크, 인크. |
Pd-1 축 결합 길항제 및 탁산을 이용한 암 치료 방법
|
CA2937539A1
(en)
|
2014-02-04 |
2015-08-13 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
CN106132439A
(zh)
|
2014-03-31 |
2016-11-16 |
豪夫迈·罗氏有限公司 |
包含抗血管发生剂和ox40结合激动剂的组合疗法
|
CA3193070A1
(en)
|
2014-05-07 |
2015-11-12 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
SG11201609963PA
(en)
|
2014-06-03 |
2016-12-29 |
Amgen Inc |
Devices and methods for assisting a user of a drug delivery device
|
EP2963057A1
(en)
|
2014-07-02 |
2016-01-06 |
Calypso Biotech SA |
Antibodies to IL-15
|
CN106794247B
(zh)
|
2014-09-15 |
2022-12-02 |
豪夫迈·罗氏有限公司 |
抗体配制剂
|
US10695506B2
(en)
|
2014-10-14 |
2020-06-30 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
EA202191513A1
(ru)
|
2014-10-23 |
2021-11-30 |
Эмджен Инк. |
Снижение вязкости фармацевтических составов
|
SG10201807625PA
(en)
|
2014-11-17 |
2018-10-30 |
Genentech Inc |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
JP2017538512A
(ja)
|
2014-12-19 |
2017-12-28 |
アムジエン・インコーポレーテツド |
ライブボタンまたはユーザインタフェースフィールドを含む薬物送達装置
|
CA2975875A1
(en)
|
2015-02-04 |
2016-08-11 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
MX2017010466A
(es)
|
2015-02-17 |
2018-06-06 |
Amgen Inc |
Dispositivo de administracion de farmacos con sujecion asistida de vacio y/o respuestas.
|
EP3981450A1
(en)
|
2015-02-27 |
2022-04-13 |
Amgen, Inc |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
KR20180018538A
(ko)
|
2015-06-17 |
2018-02-21 |
제넨테크, 인크. |
Pd-1 축 결합 길항제 및 탁산을 사용하여 국소적 진행성 또는 전이성 유방암을 치료하는 방법
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
TW202340452A
(zh)
|
2015-08-04 |
2023-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
ES2964640T3
(es)
|
2015-08-13 |
2024-04-08 |
Amgen Inc |
Filtración en profundidad cargada de proteínas de unión al antígeno
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
AU2016381694A1
(en)
|
2015-12-30 |
2018-07-05 |
Genentech, Inc. |
Use of tryptophan derivatives for protein formulations
|
US10525137B2
(en)
|
2015-12-30 |
2020-01-07 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
CA3006529A1
(en)
|
2016-01-08 |
2017-07-13 |
F. Hoffmann-La Roche Ag |
Methods of treating cea-positive cancers using pd-1 axis binding antagonists and anti-cea/anti-cd3 bispecific antibodies
|
EP3411396A1
(en)
|
2016-02-04 |
2018-12-12 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
EP3430054B1
(en)
|
2016-03-15 |
2021-12-29 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
ES2959783T3
(es)
|
2016-05-13 |
2024-02-28 |
Amgen Inc |
Conjunto de cubierta protectora de vial
|
EP3458988B1
(en)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
EP3465124A1
(en)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
US20180002417A1
(en)
|
2016-06-15 |
2018-01-04 |
Celimmune Llc |
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
EP3497129A1
(en)
|
2016-08-08 |
2019-06-19 |
H. Hoffnabb-La Roche Ag |
Therapeutic and diagnostic methods for cancer
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
US11459401B2
(en)
|
2016-10-06 |
2022-10-04 |
Amgen Inc. |
Reduced viscosity protein pharmaceutical formulations
|
BR112019007858A2
(pt)
*
|
2016-10-21 |
2019-07-02 |
Amgen Inc |
formulações farmacêuticas e métodos para produzir as mesmas
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
AR110414A1
(es)
*
|
2016-12-21 |
2019-03-27 |
Cephalon Inc |
Anticuerpos que se unen específicamente a il-15 humana y usos de estos
|
EP3559047A1
(en)
|
2016-12-23 |
2019-10-30 |
Novartis AG |
Factor xi antibodies and methods of use
|
CA3049780A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
JP7064501B2
(ja)
|
2017-02-17 |
2022-05-10 |
アムジエン・インコーポレーテツド |
無菌流体流路を備える薬物送達デバイスおよび関連する組立方法
|
JP7280189B2
(ja)
|
2017-02-17 |
2023-05-23 |
アムジエン・インコーポレーテツド |
薬物送達装置用の挿入機構
|
EP3592403A1
(en)
|
2017-03-06 |
2020-01-15 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
CA3052482A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
IL268386B2
(en)
|
2017-03-09 |
2023-11-01 |
Amgen Inc |
Insertion mechanism for a drug delivery device
|
CN114588404A
(zh)
|
2017-03-28 |
2022-06-07 |
美国安进公司 |
柱塞杆和注射器组件***以及方法
|
US11278505B2
(en)
|
2017-04-24 |
2022-03-22 |
University Of Massachusetts |
Diagnosis and treatment of vitiligo
|
CA3059369A1
(en)
|
2017-04-28 |
2018-11-01 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
EP3634546A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Torque driven drug delivery device
|
JP7195276B2
(ja)
|
2017-06-22 |
2022-12-23 |
アムジエン・インコーポレーテツド |
デバイス起動による衝突/衝撃の低減
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
WO2019018169A1
(en)
|
2017-07-21 |
2019-01-24 |
Amgen Inc. |
PERMEABLE GAS SEALING ELEMENT FOR MEDICINE CONTAINER AND METHODS OF ASSEMBLY
|
EP3658203B1
(en)
|
2017-07-25 |
2022-08-31 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
WO2019028191A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
SYSTEMS AND METHODS FOR PERFORMING REAL-TIME GLYCAN ASSAY OF A SAMPLE
|
US20200355582A1
(en)
|
2017-08-01 |
2020-11-12 |
Amgen Inc. |
Systems and Methods for Performing a Real-Time Assay of a Sample
|
WO2019032482A2
(en)
|
2017-08-09 |
2019-02-14 |
Amgen Inc. |
HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
EP4257164A3
(en)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
EP3694578A1
(en)
|
2017-10-09 |
2020-08-19 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
WO2019090086A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
US11191904B2
(en)
|
2017-11-10 |
2021-12-07 |
Amgen Inc. |
Plungers for drug delivery devices
|
MA50904A
(fr)
|
2017-11-16 |
2020-09-23 |
Amgen Inc |
Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
|
MA50903A
(fr)
|
2017-11-16 |
2021-05-12 |
Amgen Inc |
Auto-injecteur avec détection de décrochage et de point d'extrémité
|
MA51617A
(fr)
|
2018-01-17 |
2020-11-25 |
Amgen Inc |
Mécanisme d'administration de médicament
|
EP3762074A1
(en)
|
2018-03-07 |
2021-01-13 |
Amgen Inc. |
Controlled dispense syringe
|
US11890450B2
(en)
|
2018-03-09 |
2024-02-06 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
CA3093396A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
CA3093699A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
WO2019190647A1
(en)
|
2018-03-30 |
2019-10-03 |
Amgen Inc. |
Camera-based drug container inspection
|
US11583633B2
(en)
|
2018-04-03 |
2023-02-21 |
Amgen Inc. |
Systems and methods for delayed drug delivery
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
EP3810653A1
(en)
|
2018-06-23 |
2021-04-28 |
F. Hoffmann-La Roche AG |
Methods of treating lung cancer with a pd-1 axis binding antagonist, a platinum agent, and a topoisomerase ii inhibitor
|
AU2019305637A1
(en)
|
2018-07-18 |
2021-03-11 |
Genentech, Inc. |
Methods of treating lung cancer with a PD-1 axis binding antagonist, an antimetabolite, and a platinum agent
|
EP3826699A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023444A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
EP3829692A1
(en)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
JP2021533149A
(ja)
|
2018-08-08 |
2021-12-02 |
ジェネンテック, インコーポレイテッド |
タンパク質製剤のためのトリプトファン誘導体及びl−メチオニンの使用
|
AU2019321678A1
(en)
|
2018-08-17 |
2021-01-28 |
Amgen Inc. |
Activation mechanism for drug delivery device
|
CA3111809A1
(en)
|
2018-09-21 |
2020-03-26 |
Genentech, Inc. |
Diagnostic methods for triple-negative breast cancer
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
CA3110529A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
WO2020072846A1
(en)
|
2018-10-05 |
2020-04-09 |
Amgen Inc. |
Drug delivery device having dose indicator
|
EA202191037A1
(ru)
|
2018-10-15 |
2021-08-05 |
Эмджен Инк. |
Устройство доставки лекарственного средства, имеющее демпферный механизм
|
AR116703A1
(es)
|
2018-10-15 |
2021-06-02 |
Amgen Inc |
Proceso de ensamblaje de plataforma para un dispositivo de administración de fármacos
|
MA54048A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
CA3126018A1
(en)
|
2018-12-14 |
2020-06-18 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
WO2020154170A1
(en)
|
2019-01-24 |
2020-07-30 |
Amgen Inc. |
Drug delivery systems and methods with back pressure sensing
|
US11534547B2
(en)
|
2019-01-24 |
2022-12-27 |
Amgen Inc. |
Drug delivery systems and methods with pressure sensitive control
|
EP3924015A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Dosing systems and approaches
|
JP2022519590A
(ja)
|
2019-02-12 |
2022-03-24 |
アムジエン・インコーポレーテツド |
連続投薬システム及び手法
|
US20220087901A1
(en)
|
2019-02-12 |
2022-03-24 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
US20220096747A1
(en)
|
2019-02-12 |
2022-03-31 |
Amgen Inc. |
Continuous dosing systems and approaches
|
EP3924014A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Take-home drug delivery system
|
EP3924019A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Continuous dosing systems and approaches
|
EP3924083B1
(en)
|
2019-02-14 |
2024-05-15 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
WO2020172293A1
(en)
|
2019-02-20 |
2020-08-27 |
Amgen Inc. |
Methods of determining protein stability
|
CA3130462A1
(en)
|
2019-03-04 |
2020-09-10 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
CA3133459A1
(en)
|
2019-03-27 |
2020-10-01 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
US11464706B2
(en)
|
2019-04-08 |
2022-10-11 |
Amgen Inc. |
Automated drug delivery device and container
|
US20220143319A1
(en)
|
2019-04-09 |
2022-05-12 |
Amgen Inc. |
Drug delivery device with smart grip
|
AU2020259327A1
(en)
|
2019-04-17 |
2021-09-16 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
EP3958925A1
(en)
|
2019-04-24 |
2022-03-02 |
Amgen Inc. |
Injector accessories
|
JP2022529319A
(ja)
|
2019-04-24 |
2022-06-21 |
アムジエン・インコーポレーテツド |
シリンジ滅菌確認アセンブリ及び方法
|
AU2020288652A1
(en)
|
2019-06-05 |
2021-11-18 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
CN114341189A
(zh)
*
|
2019-06-12 |
2022-04-12 |
奥美药业有限公司 |
全新il-15前药及其应用
|
JP2022536471A
(ja)
|
2019-06-20 |
2022-08-17 |
アムジエン・インコーポレーテツド |
無線通信可能な薬剤送出デバイス及び方法
|
WO2021011717A1
(en)
|
2019-07-18 |
2021-01-21 |
Amgen Inc. |
Sealing arrangement for drug delivery device
|
WO2021011716A1
(en)
|
2019-07-18 |
2021-01-21 |
Amgen Inc. |
Drug delivery device having pressurized vessel
|
CA3148032A1
(en)
|
2019-08-01 |
2021-02-04 |
Amgen Inc. |
Drug delivery device with temperature measurement and related method
|
EP4017560A2
(en)
|
2019-08-23 |
2022-06-29 |
Amgen, Inc |
Drug delivery device with configurable needle shield engagement components and related methods
|
AU2020340905A1
(en)
|
2019-09-03 |
2022-03-10 |
Amgen Inc. |
Activatable injection device for drug delivery
|
MX2022002355A
(es)
|
2019-09-03 |
2022-04-06 |
Amgen Inc |
Dispositivo de inyeccion para suministro de farmacos y envase para el dispositivo de inyeccion.
|
EP4028078A1
(en)
|
2019-09-12 |
2022-07-20 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
EP4031208A1
(en)
|
2019-09-16 |
2022-07-27 |
Amgen Inc. |
Method for external sterilization of drug delivery device
|
US20210121633A1
(en)
|
2019-09-30 |
2021-04-29 |
Amgen Inc. |
Drug delivery device
|
AU2020357708A1
(en)
|
2019-09-30 |
2022-03-17 |
Amgen Inc. |
Drug delivery device and methods of delivering a drug
|
CA3151476A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
BR112022005836A2
(pt)
|
2019-09-30 |
2022-06-21 |
Amgen Inc |
Dispositivo de administração de fármaco
|
CN114555155A
(zh)
|
2019-09-30 |
2022-05-27 |
美国安进公司 |
药物递送装置
|
CA3151480A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
EP4041347A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Drug delivery device with fingerprint sensor
|
WO2021071780A1
(en)
|
2019-10-07 |
2021-04-15 |
Amgen Inc. |
Drug delivery devices having light-activated ultrasonic fluid delivery
|
WO2021071763A1
(en)
|
2019-10-07 |
2021-04-15 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US20220340326A1
(en)
|
2019-10-07 |
2022-10-27 |
Amgen Inc. |
Packages for pharmaceutical products and methods of assembly
|
EP4041344A1
(en)
|
2019-10-08 |
2022-08-17 |
Amgen Inc. |
Temperature indicator for drug delivery device
|
AU2020363623A1
(en)
|
2019-10-08 |
2022-03-17 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
WO2021071886A1
(en)
|
2019-10-08 |
2021-04-15 |
Amgen Inc. |
Drug delivery device
|
EP4041341A1
(en)
|
2019-10-08 |
2022-08-17 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US20240066215A1
(en)
|
2019-10-18 |
2024-02-29 |
Amgen Inc. |
Drug delivery device and system
|
US20220331203A1
(en)
|
2019-10-18 |
2022-10-20 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
EP4045110A2
(en)
|
2019-10-18 |
2022-08-24 |
Amgen Inc. |
Drug delivery device and system
|
AU2020366423A1
(en)
|
2019-10-18 |
2022-04-14 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
EP4048346A1
(en)
|
2019-10-21 |
2022-08-31 |
Amgen Inc. |
Drug product container and drug delivery system
|
US20220387700A1
(en)
|
2019-10-24 |
2022-12-08 |
Amgen Inc. |
Systems and methods for drug delivery
|
CA3158772A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and approaches for drug delivery
|
EP4048345A1
(en)
|
2019-10-24 |
2022-08-31 |
Amgen, Inc |
Drug delivery device and system
|
WO2021081161A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and components for drug delivery and components for preparation of the same
|
US20220387702A1
(en)
|
2019-10-24 |
2022-12-08 |
Amgen Inc. |
Drug delivery device
|
US20220395635A1
(en)
|
2019-11-07 |
2022-12-15 |
Amgen Inc. |
Drug delivery system and method of use
|
WO2021113101A1
(en)
|
2019-12-02 |
2021-06-10 |
Amgen Inc. |
Lockout mechanism for drug delivery device
|
EP4069331A1
(en)
|
2019-12-05 |
2022-10-12 |
Amgen Inc. |
Flow restrictor for drug delivery device
|
EP4087864A1
(en)
|
2020-01-11 |
2022-11-16 |
Askgene Pharma, Inc. |
Novel masked cytokines and methods of use thereof
|
US20210213210A1
(en)
|
2020-01-13 |
2021-07-15 |
Amgen Inc. |
Needle shield removers, drug delivery devices, and related methods
|
CA3167020A1
(en)
|
2020-02-24 |
2021-09-02 |
Amgen Inc. |
Containers and systems for use during external sterilization of drug delivery devices
|
WO2021188223A1
(en)
|
2020-03-16 |
2021-09-23 |
Amgen Inc. |
Drug delivery member insertion sensing assemblies, drug delivery devices, and related methods
|
EP4121145A1
(en)
|
2020-03-17 |
2023-01-25 |
Amgen Inc. |
Controlled dispense syringe
|
WO2021221845A1
(en)
|
2020-04-28 |
2021-11-04 |
Amgen Inc. |
Packaging label
|
AU2021277192A1
(en)
|
2020-05-22 |
2022-11-17 |
Amgen Inc. |
Storage system and method for storing and transporting medicament
|
WO2021257503A1
(en)
|
2020-06-16 |
2021-12-23 |
Genentech, Inc. |
Methods and compositions for treating triple-negative breast cancer
|
WO2022051445A1
(en)
|
2020-09-02 |
2022-03-10 |
Amgen Inc. |
Easy open apparatus for medicament storage carton
|
WO2022055779A1
(en)
|
2020-09-09 |
2022-03-17 |
Amgen Inc. |
Swallowable drug delivery devices
|
WO2022055761A1
(en)
|
2020-09-11 |
2022-03-17 |
Amgen Inc. |
Inline uv flow device for sterilizing flow cytometry sheath fluid
|
CA3195365A1
(en)
|
2020-09-18 |
2022-03-24 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
MX2023003861A
(es)
|
2020-10-12 |
2023-04-14 |
Amgen Inc |
Metodos y aparatos de almacenamiento de medicamentos a largo plazo.
|
CA3193367A1
(en)
|
2020-11-04 |
2022-05-12 |
Jakob Halkjaer Pedersen |
Drug delivery device assembly and accessory for drug delivery device
|
EP4240451A1
(en)
|
2020-11-04 |
2023-09-13 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
US20230277778A1
(en)
|
2020-11-04 |
2023-09-07 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
CA3196039A1
(en)
|
2020-11-04 |
2022-05-12 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
AU2021376246A1
(en)
|
2020-11-05 |
2023-06-08 |
Amgen Inc. |
Materials and methods for protein processing
|
WO2022169725A1
(en)
|
2021-02-03 |
2022-08-11 |
Amgen Inc. |
High-throughput automated reconstitution of lyophilized drug product
|
EP4288017A1
(en)
|
2021-02-03 |
2023-12-13 |
Amgen Inc. |
Coaxial needle adapter and guide bracket for robotic liquid handling platform
|
US20240103025A1
(en)
|
2021-02-03 |
2024-03-28 |
Amgen Inc. |
Systems and approaches for drug processing
|
WO2022192100A1
(en)
|
2021-03-08 |
2022-09-15 |
Amgen Inc. |
Manufacturing process for hollow plunger rod
|
BR112023017793A2
(pt)
|
2021-03-10 |
2023-10-03 |
Amgen Inc |
Dispositivo de administração de fármacos
|
AU2022234298A1
(en)
|
2021-03-10 |
2023-08-31 |
Amgen Inc. |
Drug delivery device, subassembly for drug delivery device, syringe holder, and method of assembly
|
EP4304680A1
(en)
|
2021-03-10 |
2024-01-17 |
Amgen Inc. |
Drug delivery device having removable cap
|
CN117136083A
(zh)
|
2021-03-25 |
2023-11-28 |
美国安进公司 |
药物递送装置
|
EP4313214A1
(en)
|
2021-03-31 |
2024-02-07 |
Amgen Inc. |
Sound-detection based injection time measurement system for drug delivery devices
|
BR112023021779A2
(pt)
|
2021-04-22 |
2023-12-26 |
Amgen Inc |
Métodos e sistemas para avaliação automatizada da qualidade de seringa
|
EP4330974A1
(en)
|
2021-04-28 |
2024-03-06 |
Amgen Inc. |
Systems for out-patient treatment of a patient, and related methods
|
EP4341945A1
(en)
|
2021-05-17 |
2024-03-27 |
Amgen Inc. |
Feedback system and method for a drug product
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
EP4348141A1
(en)
|
2021-06-01 |
2024-04-10 |
Amgen Inc. |
Lyophilization system
|
CA3216885A1
(en)
|
2021-06-08 |
2022-12-15 |
Amgen Inc. |
Drug delivery devices, finger-grip elements, and related methods
|
IL309176A
(en)
|
2021-06-17 |
2024-02-01 |
Amgen Inc |
Drug delivery device with shock absorber
|
AU2022296519A1
(en)
|
2021-06-23 |
2024-01-18 |
Amgen Inc. |
Syringes, assemblies, and methods of manufacture
|
EP4363002A1
(en)
|
2021-06-28 |
2024-05-08 |
Amgen Inc. |
Safety device for drug delivery system
|
WO2023287562A1
(en)
|
2021-07-16 |
2023-01-19 |
Amgen Inc. |
Systems and approaches for drug processing single-use hardware
|
CA3228140A1
(en)
|
2021-09-29 |
2023-04-06 |
Amgen Inc. |
Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes
|
AR127250A1
(es)
|
2021-10-06 |
2024-01-03 |
Amgen Inc |
Herramienta de freno activado por impacto para dispositivo de administración de fármacos
|
CA3233406A1
(en)
|
2021-10-06 |
2023-04-13 |
Amgen Inc. |
Impact activated retention feature for drug delivery device
|
AU2022366707A1
(en)
|
2021-10-11 |
2024-03-14 |
Amgen Inc. |
Characterization apparatus for drug delivery devices or subcomponents thereof
|
AU2022382741A1
(en)
|
2021-11-05 |
2024-04-04 |
Amgen Inc. |
Drug delivery devices, components for use within drug delivery devices
|
WO2023086793A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
WO2023097069A1
(en)
|
2021-11-29 |
2023-06-01 |
Amgen Inc. |
Plunger rod removal force method and fixture
|
TW202335692A
(zh)
|
2021-12-03 |
2023-09-16 |
美商安進公司 |
注射器中的塞子放置
|
WO2023172592A1
(en)
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023196111A1
(en)
|
2022-04-06 |
2023-10-12 |
Amgen Inc. |
Packaging for drug delivery device
|
WO2024028448A1
(en)
|
2022-08-04 |
2024-02-08 |
Calypso Biotech Sa |
Il-15 inhibitors useful for the treatment of atopic dermatitis
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024039575A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield for syringe
|
WO2024039707A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield assembly for a syringe
|
WO2024049793A1
(en)
|
2022-08-30 |
2024-03-07 |
Amgen Inc. |
System and method of limiting subvisible particles in a syringe
|
CN117209605B
(zh)
*
|
2023-11-09 |
2024-01-30 |
北京百普赛斯生物科技股份有限公司 |
特异性结合il-15的抗体及其应用
|